このエントリーをはてなブックマークに追加
ID 62446
フルテキストURL
著者
Umeda, Yuzo Department of Gastroenterological Surgery Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID researchmap
Mitsuhashi, Toshiharu Center for Innovative Clinical Medicine, Okayama University Hospital Kaken ID researchmap
Kojima, Toru Department of Surgery, Okayama Saiseikai General Hospital
Satoh, Daisuke Department of Surgery, Hiroshima Citizens Hospital researchmap
Sui, Kenta Department of Surgery, Kochi Health Sciences Center
Endo, Yoshikatsu Department of Surgery, Himeji Red Cross Hospital
Inagaki, Masaru Department of Surgery, National Hospital Organization Fukuyama Medical Center
Oishi, Masahiro Department of Surgery, Tottori Municipal Hospital
Yagi, Takahito Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Fujiwara, Toshiyoshi Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
抄録
Background: Lymph node metastasis (LNM) has been established as a critical risk factor for prognosis in intrahepatic cholangiocarcinoma (ICC). The clinical implications of lymph node dissection (LND) have been debated. This study aimed to clarify the prognostic impact of LND by multicenter retrospective analysis.

Methods: A total of 310 ICC patients who had undergone curative resection between 2000 and 2016 were retrospectively analyzed. The prognostic impact of LND was estimated under an inverse probability of treatment weighting (IPTW) approach using propensity scores.

Results: LND was performed for 224 patients (72%), with LNM pathologically confirmed in 90 patients (40%). Prognosis was poorer for patients with LNM (median survival, 16.9 months) than for those without (57.2 months; P < .0001). One-, 3-, and 5-year overall survival rates (OS) were comparable among LND+ (81.6%, 48.0%, and 37.5%, respectively) and LND- groups (81.6%, 55.4%, and 44.6%, respectively). However, advanced tumor, as characterized by larger tumor, multinodular lesions, and serosal invasion, was significantly more frequent in the LND+ group than in the LND- group. After IPTW adjusting for imbalances, 1-, 3-, and 5-year OS were better in the LND+ group (83.5%, 52.2%, and 42.8%, respectively) than in the LND- group (71.9%, 32.4%, and 23.4%, respectively; P = .046). LND thus showed significant prognostic impact (hazard ratio = 0.58, 95%CI = |0.39|-|0.84|, P = .005), especially in hilar ICC. However, peripheral ICC displayed no therapeutic benefit from LND.

Conclusions: LND could have a significant role to play in improving oncologic outcomes. Therapeutic LND should be implemented on the basis of tumor location and tumor advancement.
キーワード
intrahepatic cholangiocarcinoma
lymph node excision
multicenter study
propensity score
retrospective studies
備考
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
発行日
2021-9-16
出版物タイトル
Journal of Hepato-Biliary-Pancreatic Sciences
出版者
Wiley
開始ページ
1
終了ページ
13
ISSN
1868-6974
NCID
AA12507209
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2021 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1002/jhbp.1038
ライセンス
http://creativecommons.org/licenses/by/4.0/
Citation
Umeda Y, Mitsuhashi T, Kojima T, Satoh D, Sui K, Endo Y, et al. Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis. J Hepatobiliary Pancreat Sci. 2021;00:1–13. https://doi.org/10.1002/jhbp.1038
助成機関名
日本学術振興会
助成番号
19K09217